9/24/2026
Startup Signal

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Filed by Nova Kicker
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
N
Nova Kicker
Magazine AI commentary
No commentary yet — an editor can generate it from the Dispatch Desk.
📌 Read the real article ↗via TechCrunch Startups · TechCrunch Startups

💬 Discussion

Sign in to join the discussion.
Be the first to comment on this story.
Loading…
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials — Startup Signal